Ignite Creation Date:
2025-12-25 @ 2:07 AM
Ignite Modification Date:
2025-12-26 @ 3:19 AM
Study NCT ID:
NCT05694260
Status:
COMPLETED
Last Update Posted:
2025-08-08
First Post:
2023-01-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Clinical Study in Children With Heterozygous Familial Hypercholesterolemia (HeFH) Aged 6 to 17 Treated Once Daily With Bempedoic Acid Oral Dosing (CLEAR Path 1)
Sponsor:
Esperion Therapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-01-12
Start Date Type:
ACTUAL
Primary Completion Date:
2025-06-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-06-04
Completion Date Type:
ACTUAL
First Submit Date:
2023-01-12
First Submit QC Date:
None
Study First Post Date:
2023-01-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-07
Last Update Post Date:
2025-08-08
Last Update Post Date Type:
ACTUAL